Fiche de COLLIN Bertrand

COLLIN Bertrand
Adresse : | ICMUB Institut de Chimie Moléculaire de l'Université de Bourgogne 9 Avenue Alain Savary 21000 Dijon - France |
E-mail : | bertrand.collin@ube.fr bcollin@cgfl.fr |
Equipe : | RITM |
Statut : | Maître de conférences HDR |
Tags : | Bioconjugaison et peptides, Chimie Biologie, Imagerie Moléculaire |
- Publications HAL
Publications HAL
Marie Josse, Eve Rigal, Nathalie Rosenblatt-Velin, Bertrand Collin, Geoffrey Dogon, et al.. Postnatally overfed mice display cardiac function alteration following myocardial infarction. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025, 1871 (1), pp.167516. ⟨10.1016/j.bbadis.2024.167516⟩. ⟨hal-04953998⟩
Pierre-Simon Bellaye, Alexandra Oudot, Jean-Marc Vrigneaud, Olivier Raguin, Francis Bichat, et al.. Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model. Contrast Media and Molecular Imaging, 2018, 2018, pp.1-11. ⟨10.1155/2018/8494031⟩. ⟨hal-03619345⟩
Lenny Pommerolle, Guillaume Beltramo, Leo Biziorek, Marin Truchi, Alexandre Magno Maneschy Dias, et al.. CD206 + macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis. Thorax, 2024, 79 (12), pp.1124-1135. ⟨10.1136/thorax-2023-221168⟩. ⟨hal-04795832⟩
Aleksandra Georgievski, Pierre-Simon Bellaye, Benjamin Tournier, Hélène Choubley, Jean-Paul Pais de Barros, et al.. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers. Cell Death and Disease, 2024, 15 (5), pp.328. ⟨10.1038/s41419-024-06715-5⟩. ⟨hal-04609481⟩
Tarik Hadi, Christophe Ramseyer, Pierre-Simon Bellaye, Tatiana Lopez, Antonin Schmitt, et al.. Lipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages. JCI Insight, 2020, 5 (24), pp.e140280. ⟨10.1172/jci.insight.140280⟩. ⟨hal-03036574v2⟩
Romane Vizier, Anaïs-Rachel Garnier, Alexandre Dias, Mathieu Moreau, Michael Claron, et al.. SPECT imaging of Lysyl Oxidase-Like 2 in a model of idiopathic pulmonary fibrosis. Molecular Pharmaceutics, 2023, 20 (7), pp.3613-3622. ⟨10.1021/acs.molpharmaceut.3c00232⟩. ⟨hal-04183933⟩
Samvel Nazaryan, Antoine Bruguière, Nelli Hovhannisyan, Tomofumi Miyamoto, Alexandre M. M. Dias, et al.. Oleanolic Acid Glycosides from Scabiosa caucasica and Scabiosa ochroleuca: Structural Analysis and Cytotoxicity. Molecules, 2023, 28 (11), pp.4329. ⟨10.3390/molecules28114329⟩. ⟨hal-04107290⟩
Robin Lescure, Malorie Privat, Jacques Pliquett, Aurélie Massot, Océane Baffroy, et al.. Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties. European Journal of Medicinal Chemistry, 2021, 220 (4), pp.113483. ⟨10.1016/j.ejmech.2021.113483⟩. ⟨hal-03436249⟩
Emma Renard, Mathieu Moreau, Pierre-Simon Bellaye, Mélanie Guillemin, Bertrand Collin, et al.. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68 Ga-Labeled Antagonists: The Chelate Makes the Difference Again. Journal of Medicinal Chemistry, 2021, 64 (12), pp.8564-8578. ⟨10.1021/acs.jmedchem.1c00523⟩. ⟨hal-04028618⟩
Gilles Crehange, Julien Boudon, Romain Boidot, Sandy Chevrier, Cecile Dalban, et al.. Preclinical development of a docetaxel nanocarrier to enhance prostate cancer radiosensitivity.. Journal of Clinical Oncology, 2015, 33 (7_suppl), pp.41. ⟨10.1200/jco.2015.33.7_suppl.41⟩. ⟨hal-03793096⟩